The Global Vulvovaginal Candidiasis Treatment Industry is on track for sustained expansion, driven by advancements in the healthcare sector and rising awareness of treatment options. A recent analysis reveals a promising outlook, with the market valued at a substantial US$1.035 billion in 2023. Looking ahead, the market is projected to reach US$1.607 billion by 2033, …